Literature DB >> 16368509

Tolerance to autoimmune thyroiditis: (CD4+)CD25+ regulatory T cells influence susceptibility but do not supersede MHC class II restriction.

Gerald P Morris1, Yi-chi M Kong.   

Abstract

Murine experimental autoimmune thyroiditis (EAT), a model of Hashimoto's thyroiditis, has served for more than three decades as a prototypical model of T cell-mediated autoimmunity. Early investigations demonstrated a clear correlation between genetic factors, particularly the H2A locus of the MHC class II region, and susceptibility to autoimmune thyroiditis. Early studies also demonstrated that susceptibility to EAT induction could be modulated by manipulation of circulating levels of thyroglobulin (Tg), the principal thyroid antigen, resulting in the strengthening of self-tolerance. This antigen-specific induced tolerance is mediated by thymus-derived cells, and subsequent investigations revealed that the suppressive function is located in the (CD4+)CD25+ T cell subset, similar to findings in other models. We have demonstrated that these (CD4+)CD25+ regulatory T cells (Treg) influence susceptibility to thyroiditis in naive, as well as mTg-tolerized mice. Here, we describe the influence of both Treg and MHC class II haplotype, independently, as well in combination, and describe our recent utilization of MHC class II transgenic mice to directly compare the extent of their influences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368509     DOI: 10.2741/1876

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  10 in total

1.  Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen.

Authors:  Gerald P Morris; Nicholas K Brown; Yi-chi M Kong
Journal:  J Autoimmun       Date:  2009-04-17       Impact factor: 7.094

2.  Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis.

Authors:  Yi-chi M Kong; Nicholas K Brown; Jeffrey C Flynn; Daniel J McCormick; Vladimir Brusic; Gerald P Morris; Chella S David
Journal:  J Autoimmun       Date:  2011-06-17       Impact factor: 7.094

Review 3.  Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation.

Authors:  Yi-chi M Kong; Wei-Zen Wei; Yaron Tomer
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.

Authors:  Jennifer B Jacob; Yi-chi M Kong; Ilke Nalbantoglu; Daniel P Snower; Wei-Zen Wei
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

5.  Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to nonfunctional antibodies.

Authors:  Alexander V Misharin; Yuji Nagayama; Holly A Aliesky; Yumiko Mizutori; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

6.  Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice.

Authors:  Suresh Kari; Jeffrey C Flynn; Muhammad Zulfiqar; Daniel P Snower; Bruce E Elliott; Yi-chi M Kong
Journal:  Thyroid       Date:  2013-09-11       Impact factor: 6.568

Review 7.  The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  J Autoimmun       Date:  2007-03-21       Impact factor: 7.094

Review 8.  Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.

Authors:  Yi-chi M Kong; Jennifer B Jacob; Jeffrey C Flynn; Bruce E Elliott; Wei-Zen Wei
Journal:  Autoimmun Rev       Date:  2009-02-28       Impact factor: 9.754

9.  Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells.

Authors:  Su He Wang; Gwo-Hsiao Chen; Yongyi Fan; Mary Van Antwerp; James R Baker
Journal:  Endocrinology       Date:  2008-11-13       Impact factor: 4.736

10.  CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients.

Authors:  Oğuz Biylgi; Bülent Karagöz; Orhan Türken; Mustafa Gültepe; Alpaslan Özgün; Tolga Tunçel; Levent Emirzeoğlu; Serkan Çelik; Tuba Müftüoğlu; Emin Gökhan Kandemir
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.